Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims to bring preventive genomics into everyday ...

New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO ...

Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...

New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE ...

Plants are usually seen as stationary life forms, quietly supporting environments. But plant communities and populations are ...

Wildlife populations that become small and isolated, often due to habitat loss, inevitably experience inbreeding which can ...

GeneDx Holdings Corp. operates as a top genomics firm which uses advanced whole exome and genome sequencing methods to diagnose rare diseases and pediatric diso ...

A tech executive utilized artificial intelligence and genomic analysis to develop a personalized experimental cancer vaccine ...

More than 2.3 million ancient genetic switches discovered in plants reveal how key growth controls endured 300 million years ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Explore our case studies highlighting groundbreaking research powered by data in the National Genomic Research Library.

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...